MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/160/0.1/19.09.25 Share Price

Warrant

DE000ME5G3T4

Market Closed - Bid/Ask 17:54:10 10/05/2024 BST Pre-market 07:03:23
0.084 EUR -3.45% Intraday chart for MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/160/0.1/19.09.25 0.089 +5.95%
Current month-20.00%
1 month-43.62%
Date Price Change Volume
10/05/24 0.084 -3.45% 0
09/05/24 0.087 -6.45% 0
08/05/24 0.093 -8.82% 0
07/05/24 0.102 +2.00% 0
06/05/24 0.1 -8.26% 0

Delayed Quote Börse Stuttgart

Last update May 10, 2024 at 05:54 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN ME5G3T
ISINDE000ME5G3T4
Date issued 15/12/2023
Strike 160 $
Maturity 19/09/2025 (495 Days)
Parity 10 : 1
Emission price 0.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.31
Lowest since issue 0.083
Spread 0.004
Spread %4.49%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.7 USD
Average target price
126.1 USD
Spread / Average Target
+20.43%
Consensus